These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24633460)

  • 1. [Statement of the Deutsche Ophthalmologische Gesellschaft (German Ophthalmological Society), the Retinologische Gesellschaft (German Retina Society) and the Berufsverband der Augenärzte Deutschlands (German Professional Association of Ophthalmologists) on the therapy of choroidal neovascularization in myopia. State: March 2014].
    Pauleikhoff D; Bertram B; Claessens D
    Ophthalmologe; 2014 Mar; 111(3):229-34. PubMed ID: 24633460
    [No Abstract]   [Full Text] [Related]  

  • 2. [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists therapy for choroidal neovascularization in myopia ].
    Pauleikhoff D; Bertram B; Claessens D; ; ;
    Klin Monbl Augenheilkd; 2014 May; 231(5):548-53. PubMed ID: 24799174
    [No Abstract]   [Full Text] [Related]  

  • 3. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
    Verteporfin in Photodynamic Therapy Study Group
    Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Photodynamic therapy: Recommendations for indication and treatment].
    Schmidt-Erfurth U; Laqua H
    Ophthalmologe; 2001 Feb; 98(2):216-9; quiz 230. PubMed ID: 11263053
    [No Abstract]   [Full Text] [Related]  

  • 5. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
    Bressler NM; Bressler SB
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):624-8. PubMed ID: 10711673
    [No Abstract]   [Full Text] [Related]  

  • 6. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
    Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
    Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal pigment epithelial tear weeks following photodynamic therapy with verteporfin for choroidal neovascularization secondary to pathologic myopia.
    Srivastava SK; Sternberg P
    Retina; 2002 Oct; 22(5):669-71. PubMed ID: 12441742
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of photodynamic therapy, ranibizumab/bevacizumab or combination in the treatment of myopic choroidal neovascularisation: a 9-year-study from a single centre.
    Rishi P; Rishi E; Bhende M; Agarwal V; Vyas CH; Valiveti M; Bhende P; Rao C; Susvar P; Sen P; Raman R; Khetan V; Murali V; Ratra D; Sharma T
    Br J Ophthalmol; 2016 Oct; 100(10):1337-40. PubMed ID: 26792945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verteporfin in Photodynamic Therapy (VIP) Study group.
    Ruiz-Oliva F; Cortés J
    Ophthalmology; 2002 Jun; 109(6):1043; author reply 1043-4. PubMed ID: 12045040
    [No Abstract]   [Full Text] [Related]  

  • 10. Intravitreal injection of bevacizumab combined with verteporfin photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
    Smith BT; Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA
    Retina; 2008 May; 28(5):675-81. PubMed ID: 18463509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation.
    Montero JA; Ruiz-Moreno JM
    Br J Ophthalmol; 2003 Feb; 87(2):173-6. PubMed ID: 12543746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Position of the Retinological Society, the German Ophthalmological Society and the Professional Association of Ophthalmologists in Germany on the current therapeutic possibilities for neovascular age-related macular degeneration].
    Klin Monbl Augenheilkd; 2007 Jul; 224(7):559-66. PubMed ID: 17657689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of intravitreal injections of ranibizumab compared to visudyne phototherapy in myopic choroidal neovascularization associated with high myopia].
    Dethorey G; Leveziel N; Lalloum F; Forte R; Guigui B; Querques G; Glacet-Bernard A; Soubrane G; Souied HÉ
    J Fr Ophtalmol; 2012 Feb; 35(2):106-12. PubMed ID: 22088356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiographic features after photodynamic therapy for choroidal neovascularisation in age related macular degeneration and pathological myopia.
    Parodi MB; Da Pozzo S; Ravalico G
    Br J Ophthalmol; 2003 Feb; 87(2):177-83. PubMed ID: 12543747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verteporfin in Photodynamic Therapy: report no. 5.
    Bandello F; Blinder K; Bressler NM; Brown AL; Miller JW; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Slakter JS; Soubrane G; Strong HA; Stur M;
    Ophthalmology; 2004 Nov; 111(11):2144. PubMed ID: 15522385
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intravitreal bevacizumab injections versus verteporferin photodynamic therapy for macular choroidal neovascularization in high myopia: 24-month follow-up].
    El Matri L; Chebil A; Bouraoui R; Kort F; Bouladi M; Basaraih S
    J Fr Ophtalmol; 2013 Jan; 36(1):29-34. PubMed ID: 23238073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of Ophthalmology.
    Ophthalmology; 2000 Dec; 107(12):2314-7. PubMed ID: 11186878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of subfoveal choroidal neovascularization in pathologic myopia with photodynamic therapy: outcomes at 1 and 2 years of follow-up].
    El Matri L; Bouraoui R; Merdassi A; Baccouri R; Mghaieth F; Ben Rejeb S; Meddeb S
    J Fr Ophtalmol; 2006 Sep; 29(7):765-70. PubMed ID: 16988626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
    Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Photodynamic therapy carefully destroys neovascularization of the retina].
    Ophthalmologe; 2003 Feb; 100(2):1 p following 174. PubMed ID: 12650171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.